These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7020738)

  • 1. Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).
    Br J Cancer; 1981 Jul; 44(1):75-80. PubMed ID: 7020738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment by radiophosphorus versus busulfan in polycythemia vera: a randomized trial (E.O.R.T.C.'s) "leukemias and hematosarcomas" group.
    Recent Results Cancer Res; 1977; (62):104-9. PubMed ID: 341245
    [No Abstract]   [Full Text] [Related]  

  • 3. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The choice of treatment in polycythaemia vera.
    Najean Y; Dresch C
    Drugs Exp Clin Res; 1986; 12(1-3):177-80. PubMed ID: 3525073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulphan treatment of polycythaemia vera.
    Brodsky I
    Br J Haematol; 1982 Sep; 52(1):1-6. PubMed ID: 7052114
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available?
    Brandt L; Anderson H
    Eur J Haematol; 1995 Jan; 54(1):21-6. PubMed ID: 7859872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polycythaemia vera.
    Loeb V
    Clin Haematol; 1975 Jun; 4(2):441-56. PubMed ID: 1102197
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre.
    Messinezy M; Pearson TC; Prochazka A; Wetherley-Mein G
    Br J Haematol; 1985 Dec; 61(4):657-66. PubMed ID: 4084455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera treated with -32p and myleran: development of chronic granulocytic leukemia with chromosomal abnormalities in one patient.
    Staven P; VAN DER Hagen CB; Vogt E; Sandnes K
    Clin Genet; 1975 Mar; 7(3):227-31. PubMed ID: 1056276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and therapy of polycythaemia vera.
    Israëls MC
    Br J Haematol; 1969 Sep; 17(3):305. PubMed ID: 5257763
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
    Tesselaar ME; Wijermans PW; Metsaars JA; Gerrits WB; Haak HL
    Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1900-2. PubMed ID: 8927166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polycythaemia vera--diagnosis and therapy].
    Lechner K; Geissler K; Gisslinger H
    Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiophosphorus therapy of polycythemia vera].
    Hör G; Pabst HW
    Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
    Rain JD
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Busulphan: effect on platelet RNA dependent DNA polymerase--implications in the treatment of polycythemia vera, thrombosis and atherosclerosis.
    Brodsky I
    Biomed Pharmacother; 1982; 36(3):125-7. PubMed ID: 6185158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with polycythemia vera on busulfan or 32P.
    Mathé G
    N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.